Business
Platinum leads immuno-oncology company HaemaLogiX’s $10m round – The Australian Financial Review
Blood cancer immuno-oncology comapny HaemaLogiX is the latest to raise capital, bringing on Platinum Asset Management as its…
KappaMab is designed to enable the immune system to recognise the abnormal cancer cells and kill them.
Platinum Asset Management fund manager Bianca Ogden said the fund had been following the progress of HaemaLogiX and believed now was the right time to…
Continue Reading
-
General19 hours agoAustralia Kangaroos lose Xavier Coates and Zac Lomax ahead of rugby league Ashes in England
-
Noosa News24 hours agoThree steps Queensland SES want you to know to Get Ready for severe weather
-
General5 hours agoPolice investigating after body found on road in Newborough, Gippsland
-
Business23 hours agoDoes Macquarie rate Karoon Energy shares a buy, hold or sell?